Author Credentials

Rondy Michael Lazaro, University of Rochester Medical Center

Kyle J. Smith, University of Rochester Medical Center

Mohammad H. Bawany, University of Rochester School of Medicine and Dentistry

Nathan Barford, University of Rochester Medical Center

Jennifer H. Paul, University of Rochester Medical Center

Author ORCID Identifier







Objective: The purpose of this pilot study is to examine patients' experience and satisfaction using telemedicine for knee and hip osteoarthritis care during the COVID-19 pandemic.

Methods: Adult patients seen via telemedicine for knee and/or hip osteoarthritis pain completed surveys through the REDCap online platform or pen/paper evaluating their experiences and satisfaction with telemedicine, assessed using yes/no and Likert scale questions. Demographic information was collected from the electronic medical record (EMR).

Results: 32 subjects (9 males, 23 females, mean age 63.2 years [SD = 12.2 years]) completed surveys. 90.6% of subjects stated that they were satisfied with the audio/video quality of their telemedicine visit. The majority of subjects responded favorably (agree or strongly agree) to survey statements about whether the doctor explained their condition/problem (93.8%), the subject understood their treatment (96.9%), the doctor answered their questions (93.8%), the doctor spent enough time during their visit (93.8%), the patient was satisfied with their telemedicine visit (90.6%), the patient was interested in future telemedicine visits (68.8%), and the patient would recommend telemedicine visits to others (78.1%).

Conclusion: Survey respondents expressed overall satisfaction and positive experiences with seeing a physiatrist for knee or hip osteoarthritis via telemedicine. Telemedicine has been demonstrated to be a useful tool for patient visits during the COVID-19 pandemic.

Creative Commons License

Creative Commons Attribution-NonCommercial 4.0 International License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License